Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers.

Fournier C, Barbier M, Camuzat A, Anquetil V, Lattante S, Clot F, Cazeneuve C, Rinaldi D, Couratier P, Deramecourt V, Sabatelli M, Belliard S, Vercelletto M, Forlani S, Jornea L; French Clinical and Genetic Research Network on FTLD/FTLD-ALS; PREVDEMALS and FTLD-Exome Study Groups, Leguern E, Brice A, Le Ber I.

Neurobiol Aging. 2019 Feb;74:234.e1-234.e8. doi: 10.1016/j.neurobiolaging.2018.09.010. Epub 2018 Sep 19.

2.

Author Correction: Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates.

Bartolome F, Esteras N, Martin-Requero A, Boutoleau-Bretonniere C, Vercelletto M, Gabelle A, Ber IL, Honda T, Dinkova-Kostova AT, Hardy J, Carro E, Abramov AY.

Sci Rep. 2018 Mar 1;8(1):4064. doi: 10.1038/s41598-018-22152-9.

3.

Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias.

Mendes A, Bertrand A, Lamari F, Colliot O, Routier A, Godefroy O, Etcharry-Bouyx F, Moreaud O, Pasquier F, Couratier P, Bennys K, Vercelletto M, Martinaud O, Laurent B, Pariente J, Puel M, Epelbaum S, Belliard S, Kaaouana T, Fillon L, Chupin M, Dubois B, Teichmann M; PHRC “CAPP” Study Group.

Neurology. 2018 Mar 20;90(12):e1057-e1065. doi: 10.1212/WNL.0000000000005165. Epub 2018 Feb 14.

PMID:
29444966
4.

Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates.

Bartolome F, Esteras N, Martin-Requero A, Boutoleau-Bretonniere C, Vercelletto M, Gabelle A, Le Ber I, Honda T, Dinkova-Kostova AT, Hardy J, Carro E, Abramov AY.

Sci Rep. 2017 May 10;7(1):1666. doi: 10.1038/s41598-017-01678-4. Erratum in: Sci Rep. 2018 Mar 1;8(1):4064.

5.

A case study for integrated STEM outreach in an urban setting using a do-it-yourself vertical jump measurement platform.

Drazan JF, Danielsen H, Vercelletto M, Loya A, Davis J, Eglash R.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:3027-3030. doi: 10.1109/EMBC.2016.7591367.

PMID:
28268950
6.

Symptomatic treatments in Alzheimer's disease in 2016: a study from Memory centers in France.

Hommet C, Novella JL, Auriacombe S, Vercelletto M, Berrut G, Belliard S, Desmidt T, Ceccaldi M.

Geriatr Psychol Neuropsychiatr Vieil. 2016 Sep 1;14(3):274-86. doi: 10.1684/pnv.2016.0629. Review.

PMID:
27651009
7.

Ugly aesthetic perception associated with emotional changes in experience of art by behavioural variant of frontotemporal dementia patients.

Boutoleau-Bretonnière C, Bretonnière C, Evrard C, Rocher L, Mazzietti A, Koenig O, Vercelletto M, Derkinderen P, Thomas-Antérion C.

Neuropsychologia. 2016 Aug;89:96-104. doi: 10.1016/j.neuropsychologia.2016.06.001. Epub 2016 Jun 2.

PMID:
27265766
8.

DAPHNE: A New Tool for the Assessment of the Behavioral Variant of Frontotemporal Dementia.

Boutoleau-Bretonnière C, Evrard C, Hardouin JB, Rocher L, Charriau T, Etcharry-Bouyx F, Auriacombe S, Richard-Mornas A, Lebert F, Pasquier F, Sauvaget A, Bulteau S, Vercelletto M, Derkinderen P, Bretonnière C, Thomas-Antérion C.

Dement Geriatr Cogn Dis Extra. 2015 Dec 18;5(3):503-16. doi: 10.1159/000440859. eCollection 2015 Sep-Dec.

9.

The Behavioral and Cognitive Executive Disorders of Stroke: The GREFEX Study.

Roussel M, Martinaud O, Hénon H, Vercelletto M, Bindschadler C, Joseph PA, Robert P, Labauge P, Godefroy O; GREFEX Study Group.

PLoS One. 2016 Jan 29;11(1):e0147602. doi: 10.1371/journal.pone.0147602. eCollection 2016.

10.

Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease?

Caroppo P, Habert MO, Durrleman S, Funkiewiez A, Perlbarg V, Hahn V, Bertin H, Gaubert M, Routier A, Hannequin D, Deramecourt V, Pasquier F, Rivaud-Pechoux S, Vercelletto M, Edouart G, Valabregue R, Lejeune P, Didic M, Corvol JC, Benali H, Lehericy S, Dubois B, Colliot O, Brice A, Le Ber I; Predict-PGRN study group.

J Alzheimers Dis. 2015;47(3):751-9. doi: 10.3233/JAD-150270.

11.

A phenotype of atypical apraxia of speech in a family carrying SQSTM1 mutation.

Boutoleau-Bretonnière C, Camuzat A, Le Ber I, Bouya-Ahmed K, Guerreiro R, Deruet AL, Evrard C, Bras J, Lamy E, Auffray-Calvier E, Pallardy A, Hardy J, Brice A, Derkinderen P, Vercelletto M.

J Alzheimers Dis. 2015;43(2):625-30. doi: 10.3233/JAD-141512.

12.

Frontotemporal dementia and its subtypes: a genome-wide association study.

Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, Hernández I, Ruiz A, Boada M, Borroni B, Padovani A, Cruchaga C, Cairns NJ, Benussi L, Binetti G, Ghidoni R, Forloni G, Galimberti D, Fenoglio C, Serpente M, Scarpini E, Clarimón J, Lleó A, Blesa R, Waldö ML, Nilsson K, Nilsson C, Mackenzie IR, Hsiung GY, Mann DM, Grafman J, Morris CM, Attems J, Griffiths TD, McKeith IG, Thomas AJ, Pietrini P, Huey ED, Wassermann EM, Baborie A, Jaros E, Tierney MC, Pastor P, Razquin C, Ortega-Cubero S, Alonso E, Perneczky R, Diehl-Schmid J, Alexopoulos P, Kurz A, Rainero I, Rubino E, Pinessi L, Rogaeva E, St George-Hyslop P, Rossi G, Tagliavini F, Giaccone G, Rowe JB, Schlachetzki JC, Uphill J, Collinge J, Mead S, Danek A, Van Deerlin VM, Grossman M, Trojanowski JQ, van der Zee J, Deschamps W, Van Langenhove T, Cruts M, Van Broeckhoven C, Cappa SF, Le Ber I, Hannequin D, Golfier V, Vercelletto M, Brice A, Nacmias B, Sorbi S, Bagnoli S, Piaceri I, Nielsen JE, Hjermind LE, Riemenschneider M, Mayhaus M, Ibach B, Gasparoni G, Pichler S, Gu W, Rossor MN, Fox NC, Warren JD, Spillantini MG, Morris HR, Rizzu P, Heutink P, Snowden JS, Rollinson S, Richardson A, Gerhard A, Bruni AC, Maletta R, Frangipane F, Cupidi C, Bernardi L, Anfossi M, Gallo M, Conidi ME, Smirne N, Rademakers R, Baker M, Dickson DW, Graff-Radford NR, Petersen RC, Knopman D, Josephs KA, Boeve BF, Parisi JE, Seeley WW, Miller BL, Karydas AM, Rosen H, van Swieten JC, Dopper EG, Seelaar H, Pijnenburg YA, Scheltens P, Logroscino G, Capozzo R, Novelli V, Puca AA, Franceschi M, Postiglione A, Milan G, Sorrentino P, Kristiansen M, Chiang HH, Graff C, Pasquier F, Rollin A, Deramecourt V, Lebert F, Kapogiannis D, Ferrucci L, Pickering-Brown S, Singleton AB, Hardy J, Momeni P.

Lancet Neurol. 2014 Jul;13(7):686-99. doi: 10.1016/S1474-4422(14)70065-1.

13.

[Frontal variant of frontotemporal dementia].

Boutoleau-Bretonniere C, Lebouvier T, Vercelletto M.

Geriatr Psychol Neuropsychiatr Vieil. 2014 Mar;12(1):63-73. doi: 10.1684/pnv.2014.0451. Review. French.

PMID:
24647240
14.

DCTN1 mutation analysis in families with progressive supranuclear palsy-like phenotypes.

Caroppo P, Le Ber I, Clot F, Rivaud-Péchoux S, Camuzat A, De Septenville A, Boutoleau-Bretonnière C, Mourlon V, Sauvée M, Lebouvier T, Bonnet AM, Levy R, Vercelletto M, Brice A; French Clinical and Genetic Research Network on Frontotemporal Dementia/Frontotemporal Dementia–Amyotrophic Lateral Sclerosis.

JAMA Neurol. 2014 Feb;71(2):208-15. doi: 10.1001/jamaneurol.2013.5100.

15.

[Dementia: Where are the Lewy bodies?].

Lebouvier T, Delrieu J, Evain S, Pallardy A, Sauvaget A, Letournel F, Chevrier R, Lepetit M, Vercelletto M, Boutoleau-Bretonnière C, Derkinderen P.

Rev Neurol (Paris). 2013 Nov;169(11):844-57. doi: 10.1016/j.neurol.2013.05.004. Epub 2013 Oct 5. Review. French.

PMID:
24103321
16.

C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing.

Le Ber I, Camuzat A, Guillot-Noel L, Hannequin D, Lacomblez L, Golfier V, Puel M, Martinaud O, Deramecourt V, Rivaud-Pechoux S, Millecamps S, Vercelletto M, Couratier P, Sellal F, Pasquier F, Salachas F, Thomas-Antérion C, Didic M, Pariente J, Seilhean D, Ruberg M, Wargon I, Blanc F, Camu W, Michel BF, Berger E, Sauvée M, Thauvin-Robinet C, Mondon K, Tournier-Lasserve E, Goizet C, Fleury M, Viennet G, Verpillat P, Meininger V, Duyckaerts C, Dubois B, Brice A.

J Alzheimers Dis. 2013;34(2):485-99. doi: 10.3233/JAD-121456.

PMID:
23254636
17.

Prospective evaluation of behavioral scales in the behavioral variant of frontotemporal dementia.

Boutoleau-Bretonnière C, Lebouvier T, Volteau C, Jaulin P, Lacomblez L, Damier P, Thomas-Anterion C, Vercelletto M.

Dement Geriatr Cogn Disord. 2012;34(2):75-82. Epub 2012 Aug 23.

PMID:
22922703
18.

Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease.

Fehlbaum-Beurdeley P, Sol O, Désiré L, Touchon J, Dantoine T, Vercelletto M, Gabelle A, Jarrige AC, Haddad R, Lemarié JC, Zhou W, Hampel H, Einstein R, Vellas B; EHTAD/002 study group.

J Alzheimers Dis. 2012;32(1):169-81.

PMID:
22785402
19.

[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].

Croisile B, Auriacombe S, Etcharry-Bouyx F, Vercelletto M; National Institute on Aging (u.s.); Alzheimer Association.

Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12. Review. French.

PMID:
22579080
20.

A genome-wide study reveals rare CNVs exclusive to extreme phenotypes of Alzheimer disease.

Rovelet-Lecrux A, Legallic S, Wallon D, Flaman JM, Martinaud O, Bombois S, Rollin-Sillaire A, Michon A, Le Ber I, Pariente J, Puel M, Paquet C, Croisile B, Thomas-Antérion C, Vercelletto M, Lévy R, Frébourg T, Hannequin D, Campion D; Investigators of the GMAJ project.

Eur J Hum Genet. 2012 Jun;20(6):613-7. doi: 10.1038/ejhg.2011.225. Epub 2011 Dec 14.

21.

Value of neuropsychological testing, imaging, and CSF biomarkers for the differential diagnosis and prognosis of clinically ambiguous dementia.

Boutoleau-Bretonnière C, Lebouvier T, Delaroche O, Lamy E, Evrard C, Charriau T, Bretonnière C, Damier P, Derkinderen P, Vercelletto M.

J Alzheimers Dis. 2012;28(2):323-36. doi: 10.3233/JAD-2011-110761.

PMID:
22008265
22.

Memantine in behavioral variant frontotemporal dementia: negative results.

Vercelletto M, Boutoleau-Bretonnière C, Volteau C, Puel M, Auriacombe S, Sarazin M, Michel BF, Couratier P, Thomas-Antérion C, Verpillat P, Gabelle A, Golfier V, Cerato E, Lacomblez L; French research network on Frontotemporal dementia.

J Alzheimers Dis. 2011;23(4):749-59. doi: 10.3233/JAD-2010-101632.

PMID:
21157021
23.

[Caregiver burden in dementia: relationships with the activities of daily living, behavioral, and psychological symptoms].

Boutoleau-Bretonnière C, Vercelletto M.

Psychol Neuropsychiatr Vieil. 2009 Dec;7 Spec No 1:15-20. doi: 10.1684/pnv.2009.0192. French.

PMID:
20061229
24.

Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation.

Sévin M, Kutalik Z, Bergman S, Vercelletto M, Renou P, Lamy E, Vingerhoets FJ, Di Virgilio G, Boisseau P, Bezieau S, Pasquier L, Rival JM, Beckmann JS, Damier P, Jacquemont S.

J Med Genet. 2009 Dec;46(12):818-24. doi: 10.1136/jmg.2008.065953. Epub 2009 Jun 18.

PMID:
19542082
25.

Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease.

Le Ber I, Camuzat A, Berger E, Hannequin D, Laquerrière A, Golfier V, Seilhean D, Viennet G, Couratier P, Verpillat P, Heath S, Camu W, Martinaud O, Lacomblez L, Vercelletto M, Salachas F, Sellal F, Didic M, Thomas-Anterion C, Puel M, Michel BF, Besse C, Duyckaerts C, Meininger V, Campion D, Dubois B, Brice A; French Research Network on FTD/FTD-MND.

Neurology. 2009 May 12;72(19):1669-76. doi: 10.1212/WNL.0b013e3181a55f1c.

PMID:
19433740
26.

Frontal Assessment Battery is a marker of dorsolateral and medial frontal functions: A SPECT study in frontotemporal dementia.

Guedj E, Allali G, Goetz C, Le Ber I, Volteau M, Lacomblez L, Vera P, Hitzel A, Hannequin D, Decousus M, Thomas-Antérion C, Magne C, Vercelletto M, Bernard AM, Didic M, Lotterie JA, Puel M, Brice A; French research network on FTD/FTD-MND, Habert MO, Dubois B.

J Neurol Sci. 2008 Oct 15;273(1-2):84-7.

PMID:
18938766
27.

[Semantic dementia: reflexions of a French working group for diagnostic criteria and constitution of a patient cohort].

Moreaud O, Belliard S, Snowden J, Auriacombe S, Basaglia-Pappas S, Bernard F, Bon L, Boutantin J, Boutoleau-Bretonnière C, Charnallet A, Coutant E, David D, Deramecourt V, Gaestel Y, Garnier S, Guichart E, Hahn-Barma V, Lebail B, Lebrun-Givois C, Lamy E, Le Carret N, Lemesle B, Memin A, Parienté J, Pasquier F, Renou P, Rouaud O, Sarazin M, Thomas-Antérion C, Vercelletto M, Virat-Brassaud ME.

Rev Neurol (Paris). 2008 Apr;164(4):343-53. doi: 10.1016/j.neurol.2008.02.031. Epub 2008 Apr 3. Review. French.

PMID:
18439926
28.

Zarit burden inventory and activities of daily living in the behavioral variant of frontotemporal dementia.

Boutoleau-Bretonnière C, Vercelletto M, Volteau C, Renou P, Lamy E.

Dement Geriatr Cogn Disord. 2008;25(3):272-7. doi: 10.1159/000117394. Epub 2008 Feb 19.

PMID:
18285675
29.

Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.

Le Ber I, Camuzat A, Hannequin D, Pasquier F, Guedj E, Rovelet-Lecrux A, Hahn-Barma V, van der Zee J, Clot F, Bakchine S, Puel M, Ghanim M, Lacomblez L, Mikol J, Deramecourt V, Lejeune P, de la Sayette V, Belliard S, Vercelletto M, Meyrignac C, Van Broeckhoven C, Lambert JC, Verpillat P, Campion D, Habert MO, Dubois B, Brice A; French research network on FTD/FTD-MND.

Brain. 2008 Mar;131(Pt 3):732-46. doi: 10.1093/brain/awn012. Epub 2008 Feb 1.

PMID:
18245784
30.

Brain spect perfusion of frontotemporal dementia associated with motor neuron disease.

Guedj E, Le Ber I, Lacomblez L, Dubois B, Verpillat P, Didic M, Salachas F, Vera P, Hannequin D, Lotterie JA, Puel M, Decousus M, Thomas-Antérion C, Magne C, Vercelletto M, Bernard AM, Golfier V, Pasquier J, Michel BF, Namer I, Sellal F, Bochet J, Volteau M, Brice A, Meininger V; French Research Network on FTD/FTD-MND, Habert MO.

Neurology. 2007 Jul 31;69(5):488-90. No abstract available.

PMID:
17664410
31.

[Semantic dementia].

Belliard S, Bon L, LeMoal S, Jonin PY, Vercelletto M, LeBail B.

Psychol Neuropsychiatr Vieil. 2007 Jun;5(2):127-38. Review. French.

32.

Progranulin null mutations in both sporadic and familial frontotemporal dementia.

Le Ber I, van der Zee J, Hannequin D, Gijselinck I, Campion D, Puel M, Laquerrière A, De Pooter T, Camuzat A, Van den Broeck M, Dubois B, Sellal F, Lacomblez L, Vercelletto M, Thomas-Antérion C, Michel BF, Golfier V, Didic M, Salachas F, Duyckaerts C, Cruts M, Verpillat P, Van Broeckhoven C, Brice A; French Research Network on FTD/FTD-MND.

Hum Mutat. 2007 Sep;28(9):846-55.

PMID:
17436289
33.

Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia.

van der Zee J, Le Ber I, Maurer-Stroh S, Engelborghs S, Gijselinck I, Camuzat A, Brouwers N, Vandenberghe R, Sleegers K, Hannequin D, Dermaut B, Schymkowitz J, Campion D, Santens P, Martin JJ, Lacomblez L, De Pooter T, Peeters K, Mattheijssens M, Vercelletto M, Van den Broeck M, Cruts M, De Deyn PP, Rousseau F, Brice A, Van Broeckhoven C.

Hum Mutat. 2007 Apr;28(4):416.

PMID:
17345602
34.

[Amyotrophic lateral sclerosis: cognitive and behavioral evaluation].

Lacomblez L, Piquard A, Vercelletto M.

Rev Neurol (Paris). 2006 Jun;162 Spec No 2:4S145-4S150. French.

PMID:
17128103
35.

Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia.

Le Ber I, Guedj E, Gabelle A, Verpillat P, Volteau M, Thomas-Anterion C, Decousus M, Hannequin D, Véra P, Lacomblez L, Camuzat A, Didic M, Puel M, Lotterie JA, Golfier V, Bernard AM, Vercelletto M, Magne C, Sellal F, Namer I, Michel BF, Pasquier J, Salachas F, Bochet J; French research network on FTD/FTD-MND, Brice A, Habert MO, Dubois B.

Brain. 2006 Nov;129(Pt 11):3051-65.

PMID:
17071924
36.

Phenotype associated with APP duplication in five families.

Cabrejo L, Guyant-Maréchal L, Laquerrière A, Vercelletto M, De la Fournière F, Thomas-Antérion C, Verny C, Letournel F, Pasquier F, Vital A, Checler F, Frebourg T, Campion D, Hannequin D.

Brain. 2006 Nov;129(Pt 11):2966-76. Epub 2006 Sep 7.

PMID:
16959815
37.

[Measurement instruments and assessment scales for frontotemporal dementia].

Vercelletto M, Lacomblez L, Renou P.

Rev Neurol (Paris). 2006 Feb;162(2):244-52. French.

PMID:
16518268
38.

APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy.

Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerrière A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M, Dubas F, Frebourg T, Campion D.

Nat Genet. 2006 Jan;38(1):24-6. Epub 2005 Dec 20.

PMID:
16369530
39.

Neuroprotection and neurodegenerative diseases: from biology to clinical practice.

Akwa Y, Allain H, Bentue-Ferrer D, Berr C, Bordet R, Geerts H, Nieoullon A, Onteniente B, Vercelletto M.

Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):226-39. Review.

PMID:
16327350
40.

Memantine enhances autonomy in moderate to severe Alzheimer's disease.

Rive B, Vercelletto M, Damier FD, Cochran J, François C.

Int J Geriatr Psychiatry. 2004 May;19(5):458-64.

PMID:
15156547
41.

[Dural arteriovenous fistula. A rare cause of treatable dementia].

Magot A, Desal H, Wiertlewski S, Houdart E, Vercelletto M, Al Hammad Ibrahim M, Guillon B.

Rev Neurol (Paris). 2004 Apr;160(4 Pt 1):425-33. Review. French.

PMID:
15103267
42.

Iatrogenic Creutzfeldt-Jakob disease subsequent to dural graft: persisting risk after 1987.

Boutoleau C, Guillon B, Martinez F, Vercelletto M, Faure A, Fève JR.

Eur J Neurol. 2003 Sep;10(5):521-3.

PMID:
12940833
43.

[Neuropsychological and scintigraphic aspects of frontotemporal dementia preceding amyotrophic lateral sclerosis].

Vercelletto M, Belliard S, Wiertlewski S, Venisse T, Magne C, Duyckaerts C, Damier P.

Rev Neurol (Paris). 2003 May;159(5 Pt 1):529-42. Review. French.

PMID:
12773898
44.

[Scales used for therapeutic trials in Alzheimer's disease].

Vercelletto M.

Rev Neurol (Paris). 2002 Sep;158(8-9):857-61. French. No abstract available.

PMID:
12386538
45.

Negative symptoms, depression and Alzheimer's disease.

Vercelletto M, Martinez F, Lanier S, Magne C, Jaulin P, Bourin M.

Int J Geriatr Psychiatry. 2002 Apr;17(4):383-7.

PMID:
11994894
46.

[Analysis of neuropsychological disorders coupled with 99m Tc-HMPAO Spect in amyotrophic lateral sclerosis. Prospective study of 16 cases].

Vercelletto M, Delchoque C, Magne C, Huvet M, Lanier S, Feve JR.

Rev Neurol (Paris). 1999 Feb;155(2):141-7. French.

PMID:
10226318
47.

Frontal type dementia preceding amyotrophic lateral sclerosis: a neuropsychological and SPECT study of five clinical cases.

Vercelletto M, Ronin M, Huvet M, Magne C, Feve JR.

Eur J Neurol. 1999 May;6(3):295-9.

PMID:
10210909
48.

[Frontal type dementia and amyotrophic lateral sclerosis. 3 cases with (HmPAO Tc99m) single-photon emission tomography study].

Vercelletto M, Bertout C, Geffriaud J, Labat JJ, Magne C, Fève JR.

Rev Neurol (Paris). 1995 Nov;151(11):640-7. Review. French.

PMID:
8745627
49.

[Anarthria, progressive apraxia and extrapyramidal syndrome: an uncommon clinical form of corticobasal degeneration? A case studied by HMPAO Tc99m single-photon emission tomography].

Fayet G, Vercelletto M, Bertout C, De Kersaint-Gilly A, Fève JR.

Rev Neurol (Paris). 1995 Apr;151(4):247-50. Review. French.

PMID:
7481375
50.

[Peripheral facial paralysis following vaccination against hepatitis B. Apropos of a case].

Ganry O, Lerailler F, Vercelletto M, Chiffoleau A, Larousse C.

Therapie. 1992 Sep-Oct;47(5):437-8. French. No abstract available.

PMID:
1299988

Supplemental Content

Loading ...
Support Center